pulmonary arterial hypertension
pulmonary arterial hypertension
Explore linked clinical trials. Standard reference: MONDO:0015924147 results · Page 1 of 6
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-08 | NCT07218029 | |
| A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, hypertensive disorder, inherited neurodegenerative disorder, interstitial lung disease, lung disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 2 | 2026-10-08 | NCT07175038 | |
| Spironolactone for Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-10-08 | NCT01712620 | |
| A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07646860 | |
| Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging | Lung Injury, acute lung injury, cardiovascular disorder, interstitial lung disease, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-10-06 | NCT07613099 | |
| Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT04273945 | |
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT03683186 | |
| A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 4 | 2026-10-02 | NCT07759804 | |
| PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial Hypertension | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, central sleep apnea syndrome, lung disorder, nervous system disorder, obstructive sleep apnea syndrome, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2026-10-01 | NCT07852403 | |
| Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in PAH. | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 1 | 2026-09-28 | NCT07751120 | |
| Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 2 | 2026-09-25 | NCT07318597 | |
| A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-25 | NCT05179876 | |
| A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-09-25 | NCT03492177 | |
| Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) | Inflammation, Insulin Resistance, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, glucose metabolism disease, hyperinsulinism, lung disorder, metabolic disease, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Not applicable | 2026-09-25 | NCT03288025 | |
| Hormonal, Metabolic, and Signaling Interactions in PAH | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Not stated | 2026-09-25 | NCT01884051 | |
| Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, interstitial lung disease, lung disorder, obstructive lung disease, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2026-09-24 | NCT07666841 | |
| Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Not yet recruiting | Not applicable | 2026-09-23 | NCT07700303 | |
| Riociguat in Children With Pulmonary Arterial Hypertension (PAH) | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-09-23 | NCT02562235 | |
| Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Active, not recruiting | Not stated | 2026-09-18 | NCT07667673 | |
| Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs | Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Disease Attributes, Fibrosis, Infant, Newborn, Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, cystic fibrosis, hereditary disease, interstitial lung disease, lung disorder, obstructive lung disease, pancreas disorder, pulmonary arterial hypertension, pulmonary emphysema, pulmonary fibrosis, pulmonary hypertension, respiratory system disorder | Enrolling by invitation | Not stated | 2026-09-18 | NCT04930289 | |
| The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-17 | NCT07824674 | |
| A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-09-16 | NCT07481981 | |
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Not yet recruiting | Phase 1 | 2026-09-14 | NCT05660863 | |
| A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT07143448 | |
| Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD) | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-09-09 | NCT07777445 |